VERTEX CELL AND GENETIC THERAPIES Trademark
Trademark Overview
On Monday, September 25, 2023, a trademark application was filed for VERTEX CELL AND GENETIC THERAPIES with the United States Patent and Trademark Office. The USPTO has given the VERTEX CELL AND GENETIC THERAPIES trademark a serial number of 98195949. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 24, 2024. This trademark is owned by Vertex Pharmaceuticals Incorporated. The VERTEX CELL AND GENETIC THERAPIES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
medical and scientific research; medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing
General Information
| Serial Number | 98195949 |
| Word Mark | VERTEX CELL AND GENETIC THERAPIES |
| Filing Date | Monday, September 25, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, September 24, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 30, 2024 |
Trademark Statements
| NOT AVAILABLE | "CELL AND GENETIC THERAPIES" |
| Goods and Services | medical and scientific research; medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 10, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Vertex Pharmaceuticals Incorporated |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
| Party Name | Vertex Pharmaceuticals Incorporated |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
Trademark Events
| Event Date | Event Description |
| Thursday, September 28, 2023 | NEW APPLICATION ENTERED |
| Friday, March 29, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, October 10, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 5, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, April 5, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, April 5, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 20, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 20, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 20, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 21, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 10, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 30, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 30, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 24, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
